Interdisciplinary epidemiologic and economic research needed to support a universal childhood influenza vaccination policy

Epidemiologic Reviews

Volumn 28, Issue 1, 2006, Pages 41-46

  Coleman, Margaret S ^a,d   Washington, Michael L ^a   Orenstein, Walter A ^b   Gazmararian, Julie A ^c   Prill, Mila M ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

Economics; Health policy; Influenza vaccines; Mass immunization; Policy making; Public health; Research

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; CHILD; CLINICAL RESEARCH; COMMUNITY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; HEALTH CARE POLICY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFLUENZA; INFLUENZA VACCINATION; MEDICAL INFORMATION; PRIORITY JOURNAL;

CHILD; CHILD HEALTH SERVICES; COMMUNICABLE DISEASE CONTROL; FEASIBILITY STUDIES; HEALTH EXPENDITURES; HEALTH POLICY; HEALTH SERVICES RESEARCH; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA, HUMAN; INTERDISCIPLINARY COMMUNICATION; NATIONAL HEALTH PROGRAMS; RESEARCH; UNITED STATES;

EID: 33747894115     PISSN: 0193936X     EISSN: 14786729     Source Type: Journal    
DOI: 10.1093/epirev/mxj008     Document Type: Article

References (24)

1. Simonsen L, Reichert TA, Viboud C, et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005;165:265-72.
2. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.
3. Influenza and pneumococcal vaccination coverage levels among persons aged greater than or equal to 65 years - United States, 1973-1993. MMWR Morb Mortal Wkly Rep 1995;44:506-507, 513-15.
4. Centers for Disease Control and Prevention. Percentage of persons aged ≥18 years who reported receiving influenza or pneumococcal vaccine or tetanus toxoid, by age and selected characteristics - National Health Interview Survey, United States, 1999. (Table). Atlanta, GA: Centers for Disease Control and Prevention, 1999. (World Wide Web URL: http://www.cdc.gov/nip/coverage/NHIS/ tables/general-99.pdf). (Accessed February 18, 2004).
5. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006;24:1159-69.
6. Fukada K, Levandowski RA, Bridges CB, et al. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 4th ed. Philadelphia, PA: W B Saunders Company, 2003:339-70.
7. Voordouw AC, Sturkenboom MC, Dieleman JP, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 2004;292:2089-95.
8. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2003;52:1-34.
9. Piedra PA, Gagliani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005;23:1540-8.
10. Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001;344:889-96.
11. Halloran ME, Longini IM Jr. Community studies for vaccinating schoolchildren against influenza. Science 2006;311:615-16.
12. Cohen J. Immunizing kids against flu may prevent deaths among the elderly. Science 2004;306:1123.
13. Monto AS, Davenport FM, Napier JA, et al. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970;122:16-25.
14. Longini IM Jr, Halloran ME. Strategy for distribution of influenza vaccine to high-risk groups and children. Am J Epidemiol 2005;161:303-6.
15. Szucs TD. Medical economics in the field of influenza - past, present, and future. Virus Res 2004;103:25-30.
16. Parente ST, Salkever DS, DaVanzo J. The role of consumer knowledge of insurance benefits in the demand for preventive health care among the elderly. Health Econ 2005;14:25-38.
17. Santoli JM, Huet NJ, Smith PJ, et al. Insurance status and vaccination coverage among US preschool children. Pediatrics 2004;113(suppl):1959-64.
18. Oster NV, McPhillips-Tangum CA, Averhoff F, et al. Barriers to adolescent immunization: a survey of family physicians and pediatricians. J Am Board Fam Pract 2005;18:13-19.
19. Lambert S, O'Grady KA, Gabriel S, et al. The cost of seasonal respiratory illnesses in Australian children: the dominance of patient and family costs and implications for vaccine use. Commun Dis Intell 2004;28:510-16.
20. Ohkusa Y. Policy evaluation for the subsidy for influenza vaccination in the elderly. Vaccine 2005;23:2256-60.
21. Coleman MS, Fontanesi J, Meltzer MI, et al. Estimating medical practice expenses from administering adult influenza vaccinations. Vaccine 2005;23:915-23.
22. Meltzer MI, Neuzil KM, Griffin MR, et al. An economic analysis of annual influenza vaccination of children. Vaccine 2005;23:1004-14.
23. Weycker D, Edelsberg J, Halloran ME, et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005;23:1284-93.
24. Glick ND, Blackmore CC, Zelman WN. Extending simulation modeling to activity-based costing for clinical procedures. J Med Sys 2000;24:77-89.